
Combining an imaging technology with a new drug that “lights up” lung cancer cells may help surgeons spot hidden bits of cancer, a new study suggests. The small, preliminary study found that the new combo — dubbed intraoperative molecular imaging (IMI) — helped improve outcomes in surgeries of 1 out of 4 patients. The drug… read on >